The objective of the present study was to investigate the antihyperlipidaemic efficacy of Trachyspermum ammi (L) Sprague, seed (Ajowan) powder in albino rabbits. Hyperlipidaemia was induced with butter ad libitum and oral intubation of cholesterol 400 mg/kg body weight. Simvastatin, (Tablet survive ® ) was used as a synthetic cholesterol lowering drug. The results suggest that 2 g/kg T. ammi seed powder produced hypolipidaemic activity, rendering 49%, 53%, 71% and 63% reduction in total lipids, triglycerides, total cholesterol and LDL-cholesterol, respectively. However, at this dosage level 62% increase in the value of HDL-cholesterol was induced by T. ammi seed powder. Nonetheless, 0.5 g/kg and 1 g/kg T. ammi seed powder did not show antihyperlipidaemic activity.
Hyperlipidaemia initiates the onset of abnormalities in lipid metabolism secondary to manifestations and progression of the atherosclerosis characterized by formation of fibro-fatty intimal plaques. Abnormalities in lipid metabolism are among the best known cardiovascular risk factors (Anderson et al. 1987) . A safe and effective hypolipidaemic modality -pharmacological, physical or dietary -can be employed to evade the predisposition to coronary heart disease. There is both animal model and human evidence that this is due to improvement in underlying atherosclerotic lesions with the reduction of both the lipid and the sclerotic components (Blankenhorn 1989) .
Several synthetic drugs have been reported to have serious side effects (Laurance and Bennett 1992; Javed et al. 1994; Bhandari et al. 2002) . Therefore, like in other ailments, attention is also being directed to medicines of herbal origin to discover safer and cheaper drugs for hypolipidaemic activity (Shaila et al. 1997; Miura et al. 2003; Wei et al. 2003; Suber 2005; Visavadiya and Narasimhacharya 2005; Javed et al. 2006) .
Trachyspermum ammi (L.) Sprague, locally known as Ajowan, is cultivated in many parts of Pakistan, India, Afghanistan, Egypt and Europe (Chopra 1985) . This plant is reported to inhibit platelet aggregation (Srivastava 1988) , to show antifungal effects (Dwivedi and Dubey 1993) and to decrease blood pressure (Aftab et al. 1995) . The antihyperlipidaemic effect of T. ammi seed powder is still not well documented. Keeping in view the medicinal value, the present study was carried out to determine the antihyperlipidaemic effect of T. ammi seed powder in albino rabbits. Normal routine feed + butter ad libitum + cholesterol powder ammi seed powder 400 mg/kg body weight in 5 ml coconut oil as vehicle 0 to 90 days, normal routine feed + T. ammi seed powder 0.5 g/kg in 5 ml water 90 to 135 days Group V: Trachyspermum Normal routine feed + butter ad libitum + cholesterol powder ammi seed powder 400 mg/kg body weight in 5 ml coconut oil as vehicle 0 to 90 days, normal routine feed + T. ammi seed powder 1g/kg in 5 ml water 90 to 135 days Group VI: Trachyspermum Normal routine feed + butter ad libitum + cholesterol powder ammi seed powder 400 mg/kg body weight in 5 ml coconut oil as vehicle 0 to 90 days, normal routine feed + T. ammi seed powder 2 g/kg in 5 ml water 90 to 135 days At the completion of the experiment, i.e. at post treatment day 135, the rabbits of all groups were sacrificed and the livers of individual animals were removed free from fat and connective tissue and stored at -20 °C until analysis. Total cholesterol was extracted from the liver by a method described by Choi 1991. The concentration of total cholesterol in this extract was determined by using commercial reagent kit as mentioned above.
Significance of the differences between the T. ammi seed powder-treated and untreated control or treated control groups was tested using Student's t-test. To assess the antihyperlipidaemic effect of T. ammi seed powder on the cholesterol contents of liver tissue, comparison between the treatment groups, treated control group and/or untreated control group was performed by analysis of variance (ANOVA) followed by Duncan's Multiple Range Test (DMR). In all tests the criterion of significance was (P < 0.05).
Results and Discussion
Hyperlipidaemia produced as a result of 0-90 days feed butter ad libitum and cholesterol 400 mg/kg body weight along with the normal routine feed is given in Fig 1. It is obvious that there was a 2.5-to 7-fold increase in lipid profile indicators at 90 days when compared to their respective values at day 0, while HDL-cholesterol was found having a 1 to 1.5 times decreasing trend. However, a 3.5-to 9-fold increase in these indicators has been reported in albino rabbits fed with atherogenic diet and cholesterol (400 mg/kg) for 120 days (Purohit and Daradka 2001) .
Antihyperlipidaemic efficacy of T. ammi seed powder at the rate of 0.5, 1 and 2 g/kg body weight against lipid profile indicators is shown in Tables 2-6. It can be seen that in case of 0.5 g/kg and 1.5 g/kg dosage levels lipid profile indicator values at post-cholesterol feeding day 90 were not significantly altered (P > 0.05) at post-treatment days 105, 120 and 135. However, the reductions in lipid profile indicators induced by 2 g/kg T. ammi seed powder was found significant (P < 0.05).
From the results it is clear that T. ammi seed powder at the level of 2 g/kg significantly lowered (P < 0.05) the lipid profile indicators, including total lipids at 135, triglycerides 8.6 ± 0.9 8.8 ± 0.9 8.9 ± 0.8 8.5 ± 0.8 ---Group II 23.7 ± 1.8 22.4 ± 1.6 22.0 ± 1.5 20.3 ± 1.4 ---Group III 20.8 ± 1.6 8.0 ± 0.9* 7.8 ± 0.8* 7.7 ± 0.6* 62 ± 5.1 63 ± 6.0 63 ± 5.7 Group IV 19.3 ± 1.6 18.5 ± 1.5 16.0 ± 1.4 15.3 ± 1.4 4 ± 0.6 17 ± 1.7 20 ± 2.2 Group V 23.3 ± 2.3 18.9 ± 2.0 17.6 ± 1.9 15.3 ± 1.7 19 ± 2.0 24 ± 2.5 34 ± 3.8 Group VI 21.0 ± 2.0 16.2 ± 2.0 15.3 ± 1.8 10.7 ± 0.6 23 ± 2.6 27 ± 3.0 @49 ± 4.2 n = Number of animals in each group * = Significantly less (P ≤ 0.05) than the pretreatment value at 90 days @ = Non-significantly (P > 0.5) different from respective value obtained with Tablet survive ® (simvastatin) 2.5 ± 0.5 2.5 ± 0.5 2.4 ± 0.5 2.4 ± 0.5 ---Group II 8.3 ± 0.8 8.0 ± 0.9 7.5 ± 1.0 7.1 ± 0.7 ---Group III 8.5 ± 0.9 3.5 ± 0.6* 2.5 ± 0.6* 2.2 ± 0.5 59 ± 7.3* 70 ± 7.8 74 ± 8.7 Group IV 10.8 ± 1.1 10.1 ± 0.9 9.2 ± 0.9 8.6 ± 0.8 6 ± 1.0 15 ± 1.7 20 ± 2.0 Group V 10.7 ± 1.2 9.9 ± 1.1 8.4 ± 1.0 7.7 ± 0.9 8 ± 0.9 22 ± 1.9 28 ± 2.2 Group VI 9.0 ± 1.2 6.2 ± 0.9 4.7 ± 0.8* 4.0 ± 0.6* 31 ± 3.6 48 ± 5.0 @55 ± 5.6 n = Number of animals in each group * = Significantly less (P ≤ 0.05) than the pretreatment value at 90 days @ = Non-significantly (P > 0.5) different from respective value obtained with Tablet survive ® (simvastatin) 18.8 ± 2.5 8.4 ± 1.0* 5.4 ± 0.8* 2.7 ± 0.7* 55 ± 4.7 71 ± 5.2 85 ± 6.6 Group IV 19.4 ± 1.7 17.0 ± 1.5 15.5 ± 1.4 15.0 ± 1.4 12 ± 0.8 20 ± 1.2 22 ± 1.1 Group V 21.2 ± 2.5 18.7 ± 2.2 16.6 ± 1.9 15.1 ± 1.8 12 ± 1.4 22 ± 1.5 28 ± 1.7 Group VI 18.1 ± 2.3 10.9 ±1.5* 10.5 ±1.2* 5.2 ± 0.8* 40 ± 3.7 42 ± 4.0 @71 ± 6.0 at 120 and 135, total cholesterol and LDL-cholesterol at 105, 120 and 150 post-treatment days. Similarly, HDL-cholesterol was found to have increased at all post-treatment days. Moreover, it can also be seen that 2 g/kg of T. ammi seed powder and simvastatin produced statistically similar effects in terms of percentage reduction of lipid profile indicators at post-treatment day 135. Furthermore, the T. ammi seed powder more effectively decreased total cholesterol by 71% and then, in the descending order, LDL-cholesterol by 63%, triglycerides by 53% and total lipids by 49% on post-treatment day 135. However, a 62% increase in the value of HDL-cholesterol was induced by T. ammi seed powder after its medication in hyperlipidaemic albino rabbits. T. ammi seed 233 n = Number of animals in each group * = Significantly less (P ≤ 0.05) than the pretreatment value at 90 days @ = Non-significantly (P > 0.5) different from respective value obtained with Tablet survive ® (simvastatin) 7.0 ± 0.8 6.3 ± 0.7 6.3 ± 0.6 6.2 ± 0.6 ---Group III 5.6 ± 0.7 2.2 ± 0.4* 2.0 ± 0.4* 1.5 ± 0.3* 61 ± 4.9 64 ± 5.0 72 ± 5.5 Group IV 7.0 ± 0.7 6.5 ± 0.6 5.8 ± 0.6 5.5 ± 0.6 7 ± 0.6 17 ± 1.3 21 ± 1.5 Group V 5.5 ± 0.6 4.7 ± 0.5 4.4 ± 0.5 4.2 ± 0.4 15 ± 1.7 20 ± 2.5 24 ± 2.9 Group VI 7.1 ± 0.5 4.2 ± 0.4* 3.5 ± 0.4* 2.6 ± 0.3* 40 ± 3.5* 50 ± 4.3 @63 ± 5.1 n = Number of animals in each group * = Significantly higher (P ≤ 0.05) than the pretreatment value at 90 days @ = Non-significantly (P > 0.5) different from respective value obtained with Tablet survive ® (simvastatin) 1.0 ± 0.1 0.8 ± 0.07 1.1 ± 0.1 0.9 ± 0.09 ---Group II 0.8 ± 0.08 0.8 ± 0.09 35 ± 3.3 37 ± 3.7 ---Group III 0.7 ± 0.04 1.08 ± 0.09* 1.14 ± 0.1* 1.2 ± 0.1* 54 ± 4.8 62 ± 5.7 72 ± 6.2 Group IV 0.7 ± 0.05 0.7 ± 0.06 0.75 ± 0.08 0.8 ± 0.07 0 ± 0 7 ± 0.2 14 ± 0.6 Group V 0.7 ± 0.08 0.73 ± 0.08 0.81 ± 0.07 0.85 ±0.06 4 ± 0.2 15 ± 0.7 22 ± 0.9 Group VI 0.7 ± 0.03 0.93 ± 0.05* 1.02 ± 0.06* 1.14 ±0.1* 32 ± 2.1 45 ± 3.0 @62 ± 3.8 Table 7 . Mean ± SEM values of total cholesterol (mg/g) in the liver of hyperlipidaemic albino rabbits at post treatment day 135 after treatment with Trachyspermum ammi seed powder and simvastatin
Mean values followed by the same letters indicate non-significant difference (P > 0.05) Groups Post treatment day 135 Group I 10.1 ± 0.3 A Group II 17.4 ± 0.3 C Group III 11.0 ± 0.5 A Group IV 16.2 ± 0.7 C Group V 15.5 ± 0.4 B Group VI 9.6 ± 0.2 A powder at the rate of 2 g/kg resulted in a significant lowering (P < 0.05) of total cholesterol of liver in comparison with cholesterol-fed rabbits (Table 7) . Moreover, it is also evident from the table that the total cholesterol lowering effect of 2 g/kg of T. ammi seed powder and simvastatin is non-significantly different (P > 0.05).
The relationship between cholesterol and coronary artery disease suggests that a reduction in cholesterol plasma level reduces the incidence of coronary events (Lipid Research Clinics Programme 1984) . In the same way, hypertriglyceridaemia has been established as an independent risk factor for coronary atherosclerosis (Carlson and Bottiger 1981) . A significant decrease of cholesterol (71%) and triglycerides (53%) after administration of T. ammi seed powder indicates its risk-reducing action.
There is an inverse relationship between plasma HDL-cholesterol level and coronary heart disease (Jahromi et al. 1993; Sharma et al. 2003) . Moreover, apo-B-containing lipoprotein fractions are thought to be responsible for cholesterol deposition in atherosclerotic plaques (Choi 1991) . Further, HDL alters the balance of non-esterified cholesterol between plasma and cell by increasing its utilization in the lecithin cholesterol acyl tranferase (LCAT) system to form cholesterol ester, which moves rapidly into the cell (Katzung 2001) . So, an increase in HDL-cholesterol and a reduction in LDL-cholesterol would be advantageous clinically. In the present study the 63% decrease in LDL-cholesterol and 62% increase in HDL-cholesterol after the administration of T. ammi seed powder may be of clinical significance. Furthermore, reduction in the total cholesterol of the liver may suggest a beneficial role of T. ammi in a hyperlipidaemic subject.
The possible mechanism of lipid alteration might be a cholestatic effect of T. ammi in the liver through enhanced removal or catabolism of lipoproteins or inhibition of HMG COA reductase and/or inhibition of lysosomal lipid hydrolytic enzymes secreted by the liver.
Thus the clinical benefits of T. ammi seed powder can be correlated with a decrease in LDL-cholesterol, an increase in HDL-cholesterol and a decrease in plasma triglycerides. Based on the results, it can safely be said that T. ammi seed powder and simvastatin are equally effective in treating hyperlipidaemia. Furthermore, comprehensive chemical and pharmacological investigations will be needed to elucidate the exact mechanism of these effects and to isolate the active principles responsible.
Účinnost semen Trachyspermum ammi pro potlačení hyperlipidémie u albino králíků Cílem této studie bylo zjistit antihyperlipidemický účinek semen z rostliny Trachyspermum ammi (L) Sprague, též nazývané Ajowan, podávané ve formě šrotu albino krá-líkům. Hyperlipidémie byla indukována nabídkou másla ad libitum a podáváním cholesterolu v dávce 400 mg/kg živé hmotnosti perorální sondou. Dále byl podáván syntetický preparát na snižování cholesterolu simvastatin (Tablet survive ® ). Z výsledků vyplývá, že 2 g/kg drcených semen T. ammi vykazuje hypolipidemickou aktivitu a snižuje celkový obsah lipidů v krvi o 49 %, množství triglyceridů o 53%, hladinu celkového cholesterolu o 71 % a redukce LDL-cholesterolu činila 63 %. Na druhou stranu došlo v důsledku podání tohoto množství drcených semen T. ammi k nárůstu HDL-cholesterolu o 62 %. Podávání šrotu z semen T. ammi v dávkách 0.5 g/kg a 1 g/kg neprokázalo žádné antihyperlipidemické působení.
Drcená semena T. ammi v dávce 2 g/kg byla v léčbě hyperlipidémie u albinotických krá-líků stejně účinná jako Simvastatin v dávce 0.6 mg/kg živé hmotnosti. Tyto dvě substance ve zmíněných dávkách také významně redukovaly obsah cholesterolu v jaterní tkáni. Lze tedy předpokládat, že mechanismus účinku těchto substancí snižujících obsah lipidů v krvi, spočívá ve zvýšeném vylučování nebo katabolismu lipoproteinů, inhibici HMGCoA reduktázy, a/nebo inhibici lyzozomálních hydrolytických enzymů zapojených v metabolismu lipidů syntetizovaných v játrech.
